• myGriffith
    • Staff portal
    • Contact Us⌄
      • Future student enquiries 1800 677 728
      • Current student enquiries 1800 154 055
      • International enquiries +61 7 3735 6425
      • General enquiries 07 3735 7111
      • Online enquiries
      • Staff phonebook
    View Item 
    •   Home
    • Griffith Research Online
    • Journal articles
    • View Item
    • Home
    • Griffith Research Online
    • Journal articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

  • All of Griffith Research Online
    • Communities & Collections
    • Authors
    • By Issue Date
    • Titles
  • This Collection
    • Authors
    • By Issue Date
    • Titles
  • Statistics

  • Most Popular Items
  • Statistics by Country
  • Most Popular Authors
  • Support

  • Contact us
  • FAQs
  • Admin login

  • Login
  • Is Kava associated with hepatotoxicity: a review article

    Author(s)
    Belling, R.
    Bhula, M.
    Carroll, G.
    Strickland, A.
    Davey, K.
    Smith, N.
    Griffith University Author(s)
    Smith, Nerida A.
    Year published
    2004
    Metadata
    Show full item record
    Abstract
    Background: Recently kava has been withdrawn from sale in Germany and France reflecting its perceived association with hepatotoxicity. Aim: This article reviews case reports of liver toxicity associated with the use of kava to determine any significant similarities or differences among these cases. Results: Seven cases of altered liver function tests and/or hepatotoxicity associated with the use of kava are reviewed, Additional cases containing few details are also included. Potential links between kava hepatotoxicity and genetic polymorphism of CYP2D6 enzymes, extraction processes and possible interactions with alcohol and ...
    View more >
    Background: Recently kava has been withdrawn from sale in Germany and France reflecting its perceived association with hepatotoxicity. Aim: This article reviews case reports of liver toxicity associated with the use of kava to determine any significant similarities or differences among these cases. Results: Seven cases of altered liver function tests and/or hepatotoxicity associated with the use of kava are reviewed, Additional cases containing few details are also included. Potential links between kava hepatotoxicity and genetic polymorphism of CYP2D6 enzymes, extraction processes and possible interactions with alcohol and other medications are discussed. Conclusion: No definitive causal relationship between kava consumption and hepatotoxicity was found. Reliable data therefore need to be collected before valid conclusions can be made. Both health professionals and consumers need to be alerted to the possibility of kava-related hepatotoxicity, accompanied by education on identifying and reporting such adverse events.
    View less >
    Journal Title
    Australian Pharmacist
    Volume
    23
    Issue
    4
    Publisher URI
    http://www.australianpharmacist.com.au
    Subject
    Pharmacology and Pharmaceutical Sciences
    Publication URI
    http://hdl.handle.net/10072/21531
    Collection
    • Journal articles

    Footer

    Disclaimer

    • Privacy policy
    • Copyright matters
    • CRICOS Provider - 00233E
    • TEQSA: PRV12076

    Tagline

    • Gold Coast
    • Logan
    • Brisbane - Queensland, Australia
    First Peoples of Australia
    • Aboriginal
    • Torres Strait Islander